Acarix AB (publ)

Acarix AB (publ)

ACIXF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$18.61M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Acarix AB (publ)Acarix AB (publ)-5.5--99%--

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$18.61 Million
Enterprise Value$-2,390,320.00
Earnings per Share$-0.04
Beta-0.22
Outstanding Shares1,240,512,000

Return

Return on Equity-99.20%ROE
Return on Assets-90.98%
Return on Invested Capital-97.87%

Valuation & Multiples

P/E Ratio-5.51P/E Ratio
PEG30.48PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue20.18
Enterprise Value to EBIT-5.28
Enterprise Value to Net Income0
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 5, 2026
EPS
-$0.00
Reported
Revenue
$288,550
Est. $238,800

Next Earnings Call

Expected Date
February 11, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
$235,200
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Acarix AB (publ)

8 employees
CEO: Aamir Mahmood

Acarix AB (publ) is a medical technology company that develops and introduces diagnostic solutions for cardiovascular conditions to markets including Germany, Sweden, the Middle East, Switzerland, Austria, and globally. Their key product...